Transaction in Own Shares: Corporate America’s Record-Breaking Buyback Surge in 2026
“In the face of market volatility driven by tariff uncertainties and geopolitical tensions, U.S. corporations are on pace for an …
achondroplasia
BridgeBio Pharma (BBIO) Narrative Is Shifting With Attruby And Late Stage Pipeline
“BridgeBio Pharma is undergoing a significant transformation as Attruby (acoramidis) establishes itself as a leading therapy in transthyretin amyloid cardiomyopathy …